-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

DEI in Clinical Trials: Where Are We Now and Where We Should Strive to be?

Scientific Workshop on Defining Goals and Utilizing Tools for Enhancing Diversity, Equity and Inclusion (DEI) in Clinical Trials in Hematology
Program: Scientific Workshops
Session: Current State and Anticipated Barriers in Increasing DEI in Hematology Clinical Trials
Friday, December 8, 2023, 2:05 PM-3:00 PM

Ruemu E. Birhiray, MD

Hematology Oncology of Indiana, PC, Indianapolis, IN

Disclosures: Birhiray: Pharmacyclics: Consultancy, Honoraria, Speakers Bureau; Janssen: Consultancy, Honoraria, Speakers Bureau; PUMA BIOTECHNOLOGY: Consultancy, Honoraria, Speakers Bureau; LILLY: Consultancy, Honoraria, Speakers Bureau; NORVATIS: Consultancy; INCYTE: Consultancy, Honoraria, Speakers Bureau; SANOFI?GENZYME: Consultancy, Honoraria, Speakers Bureau; DOVA: Honoraria, Speakers Bureau; EXELIXIS: Consultancy, Honoraria, Speakers Bureau; BMS: Consultancy, Honoraria, Speakers Bureau; ABBVIE: Consultancy, Honoraria, Speakers Bureau; ASTRAZENECA: Consultancy, Honoraria, Speakers Bureau; BAYER: Consultancy, Honoraria, Speakers Bureau; ARRAY BIOPHARMA: Consultancy, Honoraria; GENENTECH: Consultancy, Honoraria; TAKEDA: Consultancy, Honoraria, Research Funding; DIACHII SANCHO: Consultancy, Honoraria, Research Funding; MORPHOSYS: Consultancy, Honoraria, Speakers Bureau; REGENERON: Consultancy, Honoraria, Research Funding, Speakers Bureau; KITE: Consultancy, Honoraria; GILEAD: Consultancy, Honoraria; IPSEN: Consultancy, Honoraria; STEMLINE: Consultancy, Honoraria; ADC Therapeutics: Consultancy, Honoraria; Genmab: Consultancy; CARIS: Consultancy, Honoraria; SERVIER: Honoraria, Speakers Bureau; AMGEN: Consultancy, Honoraria, Speakers Bureau; TerSera: Consultancy, Honoraria; Coherus: Consultancy, Honoraria, Speakers Bureau.

See more of: Current State and Anticipated Barriers in Increasing DEI in Hematology Clinical Trials
See more of: Scientific Workshop on Defining Goals and Utilizing Tools for Enhancing Diversity, Equity and Inclusion (DEI) in Clinical Trials in Hematology
See more of: Scientific Workshops
<< Previous Presentation | Next Presentation >>